These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2283481)

  • 1. Significance of CA 72.4 serum levels in gastrointestinal diseases.
    Piantino P; Taccone W; Fusaro A; Daziano E; Polloni R; Mosso R
    Int J Biol Markers; 1990; 5(2):77-80. PubMed ID: 2283481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer.
    Ychou M; Duffour J; Kramar A; Gourgou S; Grenier J
    Dis Markers; 2000; 16(3-4):105-10. PubMed ID: 11381189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of CA 72-4, CA 19-9 and CEA in the diagnosis and monitoring of gastric cancer.
    Safi F; Kuhns V; Beger HG
    Int J Biol Markers; 1995; 10(2):100-6. PubMed ID: 7561233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum sialyl-Tn antigen levels in patients with digestive cancers.
    Motoo Y; Kawakami H; Watanabe H; Satomura Y; Ohta H; Okai T; Makino H; Toya D; Sawabu N
    Oncology; 1991; 48(4):321-6. PubMed ID: 1891175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostic usefulness of Ca 19-9 antigen in cancer of the pancreas and neoplasms of the pancreato-biliary intersection].
    Robles-Diáz G; Aceves G; Galván E
    Gac Med Mex; 1990; 126(2):78-82; discussion 82-3. PubMed ID: 2387490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of a new tumour marker CA 242 with CA 19-9, CA 50 and carcinoembryonic antigen (CEA) in digestive tract diseases.
    Kuusela P; Haglund C; Roberts PJ
    Br J Cancer; 1991 Apr; 63(4):636-40. PubMed ID: 2021550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CA 72-4 compared with CEA and CA 19-9 as a marker of some gastrointestinal malignancies.
    Lopez JB; Royan GP; Lakhwani MN; Mahadaven M; Timor J
    Int J Biol Markers; 1999; 14(3):172-7. PubMed ID: 10569140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour markers CA 19-9 and CA 50 in digestive tract malignancies.
    Haglund C; Roberts PJ; Jalanko H; Kuusela P
    Scand J Gastroenterol; 1992; 27(3):169-74. PubMed ID: 1502477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical evaluation of the efficacy of the combined determination of serum markers CEA, CA 19.9, CA 72.4 as indexes of gastro-intestinal tract neoplasms].
    Marchei P; Cifaldi L; De Benedetto A; Santini D; Manna A; Trasatti L; Marchei GG; Reale MG
    G Ital Oncol; 1990; 10(4):121-4. PubMed ID: 2093080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of CA 72-4 in colorectal carcinoma. Comparison with CEA and CA 19-9.
    Fernández-Fernández L; Tejero E; Tieso A
    Eur J Surg Oncol; 1995 Aug; 21(4):388-90. PubMed ID: 7664904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of the tumor marker CA 15-3 in diagnosing and monitoring breast cancer. A comparative study with carcinoembryonic antigen.
    Safi F; Kohler I; Röttinger E; Beger H
    Cancer; 1991 Aug; 68(3):574-82. PubMed ID: 2065278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of serum CA 195 and carcinoembryonic antigen in metastatic carcinoma.
    Verdi CJ; Ahmann FR; Schifman RB; Elvick AL; Ahmann ME; Marx PC
    Cancer; 1993 Jun; 71(11):3625-32. PubMed ID: 8490911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour marker CA 125 in patients with digestive tract malignancies.
    Haglund C; Kuusela P; Roberts P; Jalanko H
    Scand J Clin Lab Invest; 1991 May; 51(3):265-270. PubMed ID: 1715601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CA 15-3 in human breast cancer. Comparison with tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA).
    Caponigro F; Iaffaioli RV; Pagliarulo C; De Placido S; Frasci G; Ungaro B; Matano E; Bianco AR
    Int J Biol Markers; 1990; 5(2):73-6. PubMed ID: 2283480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEA.
    Haglund C; Lundin J; Kuusela P; Roberts PJ
    Br J Cancer; 1994 Sep; 70(3):487-92. PubMed ID: 8080735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum values of CA72.4 in patients with gastrointestinal system tumors comparison with CEA and CA 19.9.
    Yasasever V; Sengün Z; Saydan N; Onat H; Dalay N
    Eur J Gynaecol Oncol; 1992; 13(5):403-8. PubMed ID: 1486919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporary elevation of CA 125 after abdominal surgical treatment for benign disease and cancer.
    Talbot RW; Jacobsen DJ; Nagorney DM; Malkasian GD; Ritts RE
    Surg Gynecol Obstet; 1989 May; 168(5):407-12. PubMed ID: 2711294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CA 72-4 serum marker--a new tool in the management of carcinoma patients.
    Guadagni F; Roselli M; Cosimelli M; Ferroni P; Spila A; Cavaliere F; Casaldi V; Wappner G; Abbolito MR; Greiner JW
    Cancer Invest; 1995; 13(2):227-38. PubMed ID: 7874576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of serum and gastric juice levels of carcinoembryonic antigen, CA19.9 and CA72.4 in patients with gastric cancer.
    Tocchi A; Costa G; Lepre L; Liotta G; Mazzoni G; Cianetti A; Vannini P
    J Cancer Res Clin Oncol; 1998; 124(8):450-5. PubMed ID: 9750022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum level of tumor markers (antigen Ca 19-9, CEA, ferritin) in digestive tumors. Their diagnostic usefulness].
    Jovin G; Stănel I; Popovici I; Oproiu A
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(3):223-9. PubMed ID: 2904162
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.